| scholarly article | Q13442814 |
| P50 | author | Guillaume Assié | Q56704824 |
| Bruno Ragazzon | Q37841591 | ||
| Jérôme Bertherat | Q40382686 | ||
| Anne-Marie Lefrançois-Martinez | Q40384765 | ||
| Isabelle Sahut-Barnola | Q40384859 | ||
| Marie Batisse-Lignier | Q40386181 | ||
| Sheerazed Boulkroun | Q41564222 | ||
| Maria-Christina Zennaro | Q41564225 | ||
| Laurence Amar | Q42862168 | ||
| P2093 | author name string | Antoine Martinez | |
| Pierre Val | |||
| Annabel Berthon | |||
| Coralie Drelon | |||
| Frédérique Tissier | |||
| Michelina Plateroti | |||
| Pierre-François Plouin | |||
| Seham Skah | |||
| Benoît Samson-Couterie | |||
| Hervé Lefèbvre | |||
| P2860 | cites work | Nuclear hormone receptor NR4A2 is involved in cell transformation and apoptosis | Q46727309 |
| Efficacy and tolerance of spironolactone in essential hypertension. | Q51628320 | ||
| Targeted disruption of beta-catenin in Sf1-expressing cells impairs development and maintenance of the adrenal cortex. | Q51953100 | ||
| The threshold level of adenomatous polyposis coli protein for mouse intestinal tumorigenesis. | Q53353779 | ||
| The 'just-right' signaling model: APC somatic mutations are selected based on a specific level of activation of the beta-catenin signaling cascade. | Q53389774 | ||
| Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism. | Q54327400 | ||
| Transcriptome analysis reveals that p53 and {beta}-catenin alterations occur in a group of aggressive adrenocortical cancers. | Q54405863 | ||
| Aldosterone-Producing Adenoma Formation in the Adrenal Cortex Involves Expression of Stem/Progenitor Cell Markers | Q57817519 | ||
| Adenovirus-delivered DKK3/WNT4 and steroidogenesis in primary cultures of adrenocortical cells | Q24303644 | ||
| Analysis of the role of Igf2 in adrenal tumour development in transgenic mouse models | Q27321080 | ||
| Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer | Q28251800 | ||
| Genetic dissection of differential signaling threshold requirements for the Wnt/beta-catenin pathway in vivo | Q28472494 | ||
| Disabled-2 is expressed in adrenal zona glomerulosa and is involved in aldosterone secretion | Q28583762 | ||
| Wnt-4 deficiency alters mouse adrenal cortex function, reducing aldosterone production | Q28585089 | ||
| Apc tumor suppressor gene is the "zonation-keeper" of mouse liver | Q28589915 | ||
| TASK channel deletion in mice causes primary hyperaldosteronism | Q30441139 | ||
| Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex | Q31038919 | ||
| Conditional deletion of beta-catenin mediated by Amhr2cre in mice causes female infertility | Q33583651 | ||
| Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism | Q33930728 | ||
| WNT4 is required for normal ovarian follicle development and female fertility. | Q34017075 | ||
| miR-29 modulates Wnt signaling in human osteoblasts through a positive feedback loop. | Q34055717 | ||
| The flavonoid quercetin in disease prevention and therapy: facts and fancies | Q34209493 | ||
| Identifying microRNA-mRNA regulatory network in colorectal cancer by a combination of expression profile and bioinformatics analysis. | Q34306416 | ||
| Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension | Q34328209 | ||
| Inactivation of the orphan nuclear receptor TR3/Nur77 inhibits pancreatic cancer cell and tumor growth | Q34334258 | ||
| Comprehensive re-sequencing of adrenal aldosterone producing lesions reveal three somatic mutations near the KCNJ5 potassium channel selectivity filter | Q34359244 | ||
| Regulation of Nur77 expression by β-catenin and its mitogenic effect in colon cancer cells. | Q34421814 | ||
| Protocol for the fast chromatin immunoprecipitation (ChIP) method | Q34615353 | ||
| Follicle-stimulating hormone/cAMP regulation of aromatase gene expression requires beta-catenin | Q34945269 | ||
| Detection of somatic beta-catenin mutations in primary pigmented nodular adrenocortical disease (PPNAD). | Q35110734 | ||
| Changes in the perceived epidemiology of primary hyperaldosteronism | Q35151575 | ||
| Convergence of 3',5'-cyclic adenosine 5'-monophosphate/protein kinase A and glycogen synthase kinase-3beta/beta-catenin signaling in corpus luteum progesterone synthesis | Q35543017 | ||
| Inhibition of β-catenin signaling by nongenomic action of orphan nuclear receptor Nur77 | Q35670308 | ||
| Therapeutic potential of quercetin to decrease blood pressure: review of efficacy and mechanisms | Q35684610 | ||
| K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension | Q36019674 | ||
| Effect of KCNJ5 mutations on gene expression in aldosterone-producing adenomas and adrenocortical cells. | Q36134732 | ||
| The potassium channel, Kir3.4 participates in angiotensin II-stimulated aldosterone production by a human adrenocortical cell line | Q36177385 | ||
| Invalidation of TASK1 potassium channels disrupts adrenal gland zonation and mineralocorticoid homeostasis | Q36391968 | ||
| MEF2A regulates the Gtl2-Dio3 microRNA mega-cluster to modulate WNT signaling in skeletal muscle regeneration | Q36444120 | ||
| miR-218 directs a Wnt signaling circuit to promote differentiation of osteoblasts and osteomimicry of metastatic cancer cells | Q36451980 | ||
| Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer | Q36510089 | ||
| Mitogenic Effect of Orphan Receptor TR3 and Its Regulation by MEKK1 in Lung Cancer Cells | Q37061820 | ||
| Beyond Wnt inhibition: new functions of secreted Frizzled-related proteins in development and disease | Q37102953 | ||
| Brachy-syndactyly caused by loss of Sfrp2 function | Q37180939 | ||
| WNT signaling in ovarian follicle biology and tumorigenesis | Q37624186 | ||
| Targeting Wnt signaling: can we safely eradicate cancer stem cells? | Q37763415 | ||
| Wnt/β-catenin signalling in adrenal physiology and tumour development | Q37935239 | ||
| Outcomes of adrenalectomy in patients with unilateral primary aldosteronism: a review | Q37991222 | ||
| Microarray, qPCR, and KCNJ5 sequencing of aldosterone-producing adenomas reveal differences in genotype and phenotype between zona glomerulosa- and zona fasciculata-like tumors | Q37996386 | ||
| Effects of a novel aldosterone synthase inhibitor for treatment of primary hypertension: results of a randomized, double-blind, placebo- and active-controlled phase 2 trial | Q38483164 | ||
| Cross-talk between NR4A orphan nuclear receptors and β-catenin signaling pathway in osteoblasts | Q39583898 | ||
| Lack of beneficial metabolic effects of quercetin in adult spontaneously hypertensive rats. | Q39776704 | ||
| Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway | Q39851799 | ||
| Frequent epigenetic inactivation of SFRP genes and constitutive activation of Wnt signaling in gastric cancer | Q40171588 | ||
| Apc modulates embryonic stem-cell differentiation by controlling the dosage of beta-catenin signaling | Q40690911 | ||
| The orphan nuclear receptors NURR1 and NGFIB regulate adrenal aldosterone production | Q42453510 | ||
| Aldosterone synthase inhibition with LCI699: a proof-of-concept study in patients with primary aldosteronism | Q42908792 | ||
| Constitutive beta-catenin activation induces adrenal hyperplasia and promotes adrenal cancer development. | Q43182598 | ||
| Salt-sensitive hypertension in circadian clock-deficient Cry-null mice involves dysregulated adrenal Hsd3b6. | Q43214302 | ||
| Trends in the prevalence of primary aldosteronism, aldosterone-producing adenomas, and surgically correctable aldosterone-dependent hypertension | Q44805596 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 889-905 | |
| P577 | publication date | 2013-10-01 | |
| P1433 | published in | Human Molecular Genetics | Q2720965 |
| P1476 | title | WNT/β-catenin signalling is activated in aldosterone-producing adenomas and controls aldosterone production | |
| P478 | volume | 23 |
| Q46722939 | ARMC5 mutation analysis in patients with primary aldosteronism and bilateral adrenal lesions. |
| Q48165772 | ARMC5 mutations in familial and sporadic primary bilateral macronodular adrenal hyperplasia. |
| Q36506804 | Activating mutations in CTNNB1 in aldosterone producing adenomas |
| Q26852504 | Adrenocortical zonation, renewal, and remodeling |
| Q92135237 | Altered expression of renin-angiotensin system receptors throughout colorectal adenoma-adenocarcinoma sequence |
| Q42366425 | CTNNB1 Mutation in Aldosterone Producing Adenoma. |
| Q39035325 | Cell signaling pathways in the adrenal cortex: Links to stem/progenitor biology and neoplasia |
| Q50079172 | Cilostazol Mediated Nurr1 and Autophagy Enhancement: Neuroprotective Activity in Rat Rotenone PD Model |
| Q38271545 | Clinicopathological correlates of adrenal Cushing's syndrome. |
| Q55129846 | Comparative Genomics and Transcriptome Profiling in Primary Aldosteronism. |
| Q35288453 | DACH1, a zona glomerulosa selective gene in the human adrenal, activates transforming growth factor-β signaling and suppresses aldosterone secretion |
| Q35800278 | Development of adrenal cortex zonation |
| Q26770421 | ENDOCRINE TUMOURS: The genomics of adrenocortical tumors |
| Q39791179 | EZH2 is overexpressed in adrenocortical carcinoma and is associated with disease progression |
| Q34520848 | Enhancing Beta-Catenin Activity via GSK3beta Inhibition Protects PC12 Cells against Rotenone Toxicity through Nurr1 Induction |
| Q90480926 | Frequency of somatic mutations in TERT promoter, TP53 and CTNNB1 genes in patients with hepatocellular carcinoma from Southern Italy |
| Q52739004 | Functional Implications of LH/hCG Receptors in Pregnancy-Induced Cushing Syndrome. |
| Q38793396 | Genetics of adrenocortical tumours |
| Q26799128 | Genetics of primary bilateral macronodular adrenal hyperplasia: a model for early diagnosis of Cushing's syndrome? |
| Q36993109 | Gonadotropin-Releasing Hormone Stimulate Aldosterone Production in a Subset of Aldosterone-Producing Adenoma. |
| Q36619098 | Inhibition of the Tcf/beta-catenin complex increases apoptosis and impairs adrenocortical tumor cell proliferation and adrenal steroidogenesis. |
| Q35680832 | LGR5 Activates Noncanonical Wnt Signaling and Inhibits Aldosterone Production in the Human Adrenal |
| Q89026053 | MRAP deficiency impairs adrenal progenitor cell differentiation and gland zonation |
| Q98386954 | Molecular Basis of Primary Aldosteronism and Adrenal Cushing Syndrome |
| Q36716084 | Molecular Heterogeneity in Aldosterone-Producing Adenomas |
| Q35726125 | Molecular and Cellular Mechanisms of Aldosterone Producing Adenoma Development |
| Q99631170 | Molecular mechanisms of ARMC5 mutations in adrenal pathophysiology |
| Q26740687 | Mouse Models Recapitulating Human Adrenocortical Tumors: What Is Lacking? |
| Q36803630 | Nurr1-Based Therapies for Parkinson's Disease. |
| Q39013180 | Of channels and pumps: different ways to boost the aldosterone? |
| Q37263731 | PKA inhibits WNT signalling in adrenal cortex zonation and prevents malignant tumour development |
| Q49788223 | PKA signaling drives reticularis differentiation and sexually dimorphic adrenal cortex renewal |
| Q98158788 | Pathogenesis and treatment of primary aldosteronism |
| Q30248429 | Primary Aldosteronism: Changing Definitions and New Concepts of Physiology and Pathophysiology Both Inside and Outside the Kidney |
| Q45567424 | Primary aldosteronism patients show skin alterations and abnormal activation of glucocorticoid receptor in keratinocytes. |
| Q36288064 | Regulation of the adrenocortical stem cell niche: implications for disease |
| Q38952304 | Regulation of zonation and homeostasis in the adrenal cortex. |
| Q90663453 | Retinoic acid receptor α as a novel contributor to adrenal cortex structure and function through interactions with Wnt and Vegfa signalling |
| Q51783800 | Review of Markers of Zona Glomerulosa and Aldosterone-Producing Adenoma Cells. |
| Q64888338 | Steroidogenic differentiation and PKA signaling are programmed by histone methyltransferase EZH2 in the adrenal cortex. |
| Q90209698 | The Biology of Normal Zona Glomerulosa and Aldosterone-Producing Adenoma: Pathological Implications |
| Q54981564 | The Many Faces of Primary Aldosteronism and Cushing Syndrome: A Reflection of Adrenocortical Tumor Heterogeneity. |
| Q37051740 | The adrenal capsule is a signaling center controlling cell renewal and zonation through Rspo3. |
| Q37593326 | The prevalence of CTNNB1 mutations in primary aldosteronism and consequences for clinical outcomes |
| Q90540475 | Timeline of Advances in Genetics of Primary Aldosteronism |
| Q37401418 | Transcriptome Pathway Analysis of Pathological and Physiological Aldosterone-Producing Human Tissues |
| Q57822882 | Tumor Cell Subtypes Based on the Intracellular Hormonal Activity in KCNJ5-Mutated Aldosterone-Producing Adenoma |
| Q34850075 | Understanding primary aldosteronism: impact of next generation sequencing and expression profiling. |
| Q34131672 | Wnt signaling inhibits adrenal steroidogenesis by cell-autonomous and non-cell-autonomous mechanisms |
Search more.